Morgan Stanley (NYSE:MS) initiated coverage on shares of GlaxoSmithKline (NYSE:GSK:LN) (NYSE: GSK), a $72.5 billion pharmaceutical giant with a 25-year track record of consistent dividend payments, ...
With Chinese firms becoming major players in drug development, the traditional balance of power in global pharmaceuticals is ...
The Conference Forum has announced the 9th annual Patients as Partners® Europe event, scheduled for May 20-21, 2025, at the Royal National Hotel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback